0001209191-23-049448.txt : 20230914 0001209191-23-049448.hdr.sgml : 20230914 20230914165150 ACCESSION NUMBER: 0001209191-23-049448 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230912 FILED AS OF DATE: 20230914 DATE AS OF CHANGE: 20230914 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LYONS GARY A CENTRAL INDEX KEY: 0001123343 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-22705 FILM NUMBER: 231255657 MAIL ADDRESS: STREET 1: 12790 EL CAMINO REAL STREET 2: C/O NEUROCRINE BIOSCIENCES CITY: SAN DIEGO STATE: CA ZIP: 92130 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROCRINE BIOSCIENCES INC CENTRAL INDEX KEY: 0000914475 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330525145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: (858) 617-7600 MAIL ADDRESS: STREET 1: 12780 EL CAMINO REAL CITY: SAN DIEGO STATE: CA ZIP: 92130 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-09-12 0 0000914475 NEUROCRINE BIOSCIENCES INC NBIX 0001123343 LYONS GARY A 12780 EL CAMINO REAL SAN DIEGO CA 92130 1 0 0 0 1 Common Stock 2023-09-12 4 M 0 5000 12.98 A 208697 D Common Stock 2023-09-12 4 S 0 5000 115.024 D 203697 D Non-Qualified Stock Option 12.98 2023-09-12 4 M 0 5000 12.98 D 2024-05-22 Common Stock 5000 5000 D The disposition reported in this Form 4 was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person on February 24, 2023. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plan subsequent to adoption of the plan. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $115.00 to $115.22. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. The reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power. Option granted May 22, 2014 and vested monthly over one year. /s/ Darin Lippoldt, Attorney-in-Fact 2023-09-14